Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Growth factor promotes new blood routes in rat brain, which may prevent stroke

01.07.2003


Injections of a stimulant agent into rat brains expanded blood vessels and improved blood flow, a finding that may lead to a new, non-invasive way to prevent stroke, researchers reported in today’s rapid access issue of Circulation: Journal of the American Heart Association.



Rats treated with the growth-promoting substance granulocyte macrophage-colony stimulating factor (GM-CSF) had almost twice as much arteriogenesis, the expansion of a brain artery, after one week compared to rats given saline solution. The increase was associated with improved circulation and accumulation of cells that are thought to play a key role in artery development.

“To the best of our knowledge, this is the first report of stimulation of arteriogenesis in the brain,” say co-lead authors Ivo R. Buschmann, M.D., and Hans-Jörg Busch, M.D. Both are investigators in the Research Group for Experimental and Clinical Arteriogenesis at Albert Ludwigs University in Freiburg, Germany.


The findings suggest that growth-stimulating substances may be a novel alternative to other stroke prevention strategies, which tend to emphasize surgery and other invasive techniques that improve blood flow to the brain, the researchers say.

Growth-stimulating factors have induced angiogenesis – the growth and expansion of tiny vessels called capillaries in the immediate vicinity of reduced blood flow – in patients with coronary artery disease. However, “angiogenesis studies have failed to improve outcome in stroke,” the researchers say.

Buschmann and Busch took a different approach. They tried to induce arteriogenesis by transforming pre-existing (collateral) arteries that were unused and located away from the blockage into functioning blood-carrying vessels capable of taking over for the blocked vessels. Arteriogenesis is an effective natural mechanism to compensate for blood flow because of blocked arteries in the heart, periphery or brain, Buschmann says.

In laboratory experiments, growth factors have stimulated collateral circulation in the extremities and in the coronary circulation. Recently, GM-CSF treatment induced arteriogenesis in a small group of patients with coronary artery disease.

To evaluate the potential of GM-CSF to stimulate arteriogenesis in the brain, Buschmann and Busch induced arterial obstructions that reduced blood flow to the brain of rats, and then injected them with the growth factor. Treatment continued for seven or 21 days. A second group of rats received saline over the same period.

The researchers studied the effects of treatment on expansion of the posterior cerebral artery (PCA), an artery that originates in the back of the brain and was not near the blocked arteries. In saline-treated rats the diameter of the PCA increased by 39 percent during the three weeks. The artery expanded much faster – 72 percent at the end of one week – in rats treated with GM-CSF. The growth factor-related arteriogenesis was associated with other evidence of improved blood flow, such as the ability to increase flow in response to carbon dioxide (a signal for reduced blood supply) and accumulation of macrophages, cells that are thought to be involved in the growth of collateral arteries.

“To the best of our knowledge, this is the first study that demonstrates an improvement of brain hemodynamic parameters (blood flow) after such treatment,” the researchers state.

Co-authors are Günter Mies, M.D., and Konstantin-Alexander Hossmann, M.D.

Carole Bullock | American Heart Association
Further information:
http://www.americanheart.org/
http://www.americanheart.org/presenter.jhtml;jsessionid=OA4I0G2TMNRAJWFZOAHCCZQ?identifier=3013235

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>